Results 211 to 220 of about 174,983 (281)

Breaking barriers: Smart vaccine platforms for cancer immunomodulation

Cancer Communications, EarlyView.
Abstract Despite significant advancements in cancer treatment, current therapies often fail to completely eradicate malignant cells. This shortfall underscores the urgent need to explore alternative approaches such as cancer vaccines. Leveraging the immune system's natural ability to target and kill cancer cells holds great therapeutic potential ...
Mohammad Mahmoudi Gomari, Taha Ghantabpour, Nima Pourgholam, Neda Rostami, Stephen M. Hatfield, Farzaneh Namazifar, Shadi Abkhiz, Seyed Sadegh Eslami, Mahsa Ramezanpour, Mahsa Darestanifarahani, Igor Astsaturov, Sidi A. Bencherif    +11 more
wiley   +1 more source

Serum-Deprivation Induces Cell Death of Rat Cultured Microglia Accompanied With Expression of Bax Protein.

, 2000
Yutaka Kōyama, Yuji Kimura, Yasuhiro Yoshioka, Daisuke Wakamatsu, Ryohei Kozaki, Hitoshi Hashimoto, Toshio Matsuda, Akemichi Baba   +7 more
openalex   +2 more sources

Do microglia metabolize fructose in Alzheimer's disease? [PDF]

J Neuroinflammation
Sturno AM, Hassell JE, Lanaspa MA, Bruce KD.   +3 more
europepmc   +1 more source

Functional Maturation of Adult Mouse Resting Microglia into an APC Is Promoted by Granulocyte-Macrophage Colony-Stimulating Factor and Interaction with Th1 Cells

, 2000
Francesca Aloisi, Roberta De Simone, Sandra Columba‐Cabezas, Giuseppe Penna, Luciano Adorini   +4 more
openalex   +1 more source

Early and Progressive Accumulation of Reactive Microglia in the Huntington Disease Brain [PDF]

, 2001
Ellen Sapp, Kimberly B. Kegel, Neil Aronin, Tsutomu Hashikawa, Yasuo Uchiyama, Koujiro Tohyama, Pradeep G. Bhide, J.-P. G. Vonsattel, Marian DiFiglia   +8 more
openalex   +1 more source

Blocking ITGA5 potentiates the efficacy of anti‐PD‐1 therapy on glioblastoma by remodeling tumor‐associated macrophages

Cancer Communications, EarlyView.
Abstract Background Glioblastoma (GBM) is largely refractory to antibodies against programmed cell death 1 (anti‐PD‐1) therapy. Fully understanding the cellular heterogeneity and immune adaptations in response to anti‐PD‐1 therapy is necessary to design more effective immunotherapies for GBM.
Rongrong Zhao, Ziwen Pan, Jiawei Qiu, Boyan Li, Yanhua Qi, Zijie Gao, Wei Qiu, Weijie Tang, Xiaofan Guo, Lin Deng, Gang Li, Hao Xue   +11 more
wiley   +1 more source

LncRNA 4933431K23Rik modulate microglial phenotype via inhibiting miR-10a-5p in spinal cord injury induced neuropathic pain. [PDF]

Sci Rep
You C, Zhou W, Ye P, Zhang L, Sun W, Tian L, Peng B, Hu M, Xu B.   +8 more
europepmc   +1 more source

Microglia in neurodegeneration: Molecular aspects [PDF]

, 2001
Peter J. Gebicke‐Haerter
openalex   +1 more source

Activated Microglia Mediate the Motor Neuron-, Synaptic Denervation- and Muscle Wasting-Changes in Burn Injured Mice. [PDF]

J Cachexia Sarcopenia Muscle
Chen J, Kitagawa Y, Xie F, Li H, Kem WR, You Z, Yasuhara S, Martyn JAJ.   +7 more
europepmc   +1 more source

Dehydroepiandrosterone inhibits lipopolysaccharide‐induced nitric oxide production in BV‐2 microglia [PDF]

, 2001
Mei‐Jen Wang, Hsueh‐Meei Huang, Huan‐Lian Chen, Jon‐Son Kuo, Kee-Ching Jeng   +4 more
openalex   +1 more source